Overview

Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

Status:
Completed
Trial end date:
2020-09-19
Target enrollment:
Participant gender:
Summary
Closed-loop system systems that are shown to alleviate the burden of carbohydrate counting without degrading glucose control are still lacking. In this proposal, the investigators aim to develop a novel, fully-automated, closed-loop system that delivers insulin and pramlintide that controls postprandial glucose levels without any input from the user.
Phase:
Phase 2
Details
Lead Sponsor:
McGill University
Collaborator:
Diabetes Canada
Treatments:
Glucagon
Glucagon-Like Peptide 1
Hormones
Insulin
Insulin, Globin Zinc
Islet Amyloid Polypeptide
Pramlintide